Many overweight people lack the feeling of being full. It was long thought that this was due to the disrupted transport of the satiety hormone leptin to the brain. That is not the case, as a group of scientists from Helmholtz Zentrum München has now shown in the International Journal of Obesity.
Stereoscopic 3D video of a mouse brain with green labeled leptin
The work was made possible by a new 3D imaging technique that allows tracking the path of the hormone in the brain as shown in the video image enclosed.
Leptin is an important satiety hormone that is produced by adipose tissue. The more fat there is in the body, the more leptin is released into the bloodstream. The hormone then crosses the blood-brain barrier to reach the brain's satiety centers. There, it activates leptin receptors in nerve cells. The receptors, in turn, send signals to the brain to stop food intake. However, if the hormone no longer elicits a response in the satiety centers, this condition is called Leptin resistance. Affected people are always hungry, as if their fat stores were not already full. Leptin resistance is a major cause of overweight and obesity.
"In obese mice and humans, leptin is released from fatty tissue into the bloodstream in high concentrations but fails to activate the satiety centers in the brain. It has long been assumed that leptin resistance is caused by a disrupted transport process," explains Luke Harrison, a doctoral student at Helmholtz Zentrum München and lead author of the study. As the ability of leptin to cross the blood-brain barrier is limited, so the theory goes, less of it reaches the satiety centers. "Our innovative 3D technique enabled us to visualize the transport of leptin for the first time and to investigate whether this theory holds up," says the scientist.
Working with biologists, pathologists and structural biologists, Harrison was able to disprove this assumption. Thanks to the new imaging method, the research team headed by Dr. Paul Pfluger, a partner in the German Center for Diabetes Research (DZD), showed that leptin reaches the brain in sufficient quantities both in thin and in obese mice. The cause of the eating disorder must therefore lie in the nerve cells themselves. "We can now narrow down the cause of leptin resistance and focus our research on the molecular mechanisms within nerve cells," says Dr. Paul Pfluger. "Once all the processes involved in our satiety behavior have been elucidated, we will be able to develop new therapies for obesity and help overweight individuals lose weight." The recent work with the mouse model is a significant advance in this direction, the biologist explains. "Restoring the body's response to leptin is an important step for obese patients in their efforts to regulate their food intake."
In fact, his research team has recently shown that the substance Celastrol, which is also used in traditional Chinese medicine, restores leptin sensitivity and lowers body weight. Initial approaches are now underway, and research at Helmholtz Zentrum München will be further intensified.